In other M&A related stories reported by Reuters and other media on Thursday:
Britain’s leading institutional investors are considering options to take control of rights issues because they are frustrated by high underwriting fees and deep-discount deals, the Times said, citing one of London’s biggest long-term shareholders.
French drugs group Sanofi-Aventis has agreed to pay $4 billion to Merck for a 50 percent stake in animal health venture Merial. The group has also agreed a possible wider new joint venture that would combine the Merial business with the similar activities of the pending $41 billion merger of Merck and Schering-Plough Corp.
New York-listed Software firm Patni Computer (PTNI.BO) told Reuters in an interview that it will seek acquisitions in Europe and the Asia-Pacific to help lower its dependence on the U.S market. CFO Surjeet Singh said the company will look at targets in the range of $50-$200 million.
This item provided by DealZone
No comments:
Post a Comment